What is the primary treatment for a patient with Mobitz type II (second-degree) atrioventricular (AV) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Treatment for Mobitz Type II AV Block

Permanent pacemaker implantation is the primary treatment for patients with Mobitz type II second-degree atrioventricular block, regardless of whether symptoms are present. 1

Understanding Mobitz Type II AV Block

Mobitz type II AV block is characterized by:

  • Intermittent non-conducted P waves without progressive PR interval prolongation
  • Usually occurs at the level of the His-Purkinje system (infranodal)
  • Often associated with a wide QRS complex
  • High risk of progression to complete heart block
  • Potential for sudden cardiac death due to asystole

Evaluation Before Pacemaker Implantation

Before proceeding with pacemaker implantation, a thorough evaluation should include:

  • Assessment for symptoms (syncope, presyncope, dizziness, fatigue, exercise intolerance)
  • ECG to confirm diagnosis and assess QRS width
  • Echocardiogram to evaluate cardiac structure and function
  • Exclusion of reversible causes (medication effects, electrolyte abnormalities)

Treatment Algorithm

  1. Acute/Temporary Management:

    • For symptomatic bradycardia: Transcutaneous pacing may be used as an urgent expedient 1
    • IV atropine may be considered for temporary management of bradycardia but is not definitive treatment 2
    • Temporary transvenous pacing for hemodynamically unstable patients
  2. Definitive Treatment:

    • Permanent pacemaker implantation is indicated for all patients with Mobitz type II AV block 1
    • This recommendation applies to both symptomatic and asymptomatic patients 1

Evidence Supporting Permanent Pacing

The recommendation for permanent pacing in Mobitz type II AV block is based on:

  • High risk of progression to complete heart block 1, 3
  • Significant risk of Adams-Stokes syndrome and sudden death 3
  • Location of block in the His-Purkinje system rather than AV node 3
  • Poor prognosis without intervention 1

Special Considerations

  • Asymptomatic patients: Permanent pacing is still recommended as a Class IIa indication due to risk of progression to complete heart block 1
  • Post-myocardial infarction: Persistent Mobitz type II AV block after MI is a Class I indication for permanent pacing 1
  • Athletes: Mobitz type II AV block is considered abnormal in athletes and requires permanent pacemaker implantation before resuming competitive sports 1
  • Congenital heart disease: Pacemaker implantation is recommended for any patient with postoperative Mobitz II second-degree AV block that is not expected to resolve 1

Common Pitfalls

  1. Misdiagnosis: Ensure accurate differentiation between Mobitz type I (Wenckebach) and Mobitz type II AV block. In cases of 2:1 AV block, it may be difficult to distinguish between the two types without electrophysiological study 1

  2. Delayed treatment: Do not wait for symptoms to develop before considering pacemaker implantation in patients with confirmed Mobitz type II AV block 3

  3. Inadequate follow-up: Even after pacemaker implantation, patients require regular follow-up to ensure proper device function and to monitor for progression of underlying conduction disease

  4. Overlooking reversible causes: While permanent pacing is typically required, always consider potentially reversible causes such as medication effects, electrolyte abnormalities, or inflammatory conditions 4, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.